Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo meaningful content changes detected. The page continues to display study details, eligibility criteria, and locations.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, plus a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference3%

- Check45 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. A 'Back to Top' navigation element was removed, a minor UI change.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has been updated to include specific drug information for Tislelizumab and detailed location data for facilities in Beijing and Shanghai, while removing some redundant location terms and previous versions of the drug information.SummaryDifference4%

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.